Company chart and information is provided by TradingView based on 15-minute-delayed data.
Chinook Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing precision medicines for kidney diseases. The products of the company are focused on rare, severe chronic kidney disorders.
Website: | www.chinooktx.com |
Email: | investors@chinooktx.com |
Main Phone: | +1 604 343-1552 |
Address: | 1600 Fairview Avenue E |
State: | WA |
City / Town: | Seattle |
Country: | US |
Postal Code: | 98102 |
Exchange: | NGS |
CEO: | Eric L. Dobmeier |
Employees: | 96 |
NAICS: | Research and Development in Biotechnology (except Nanobiotechnology)(541714) |
Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
Open N/A | High N/A | Low N/A | Prev Close N/A |
Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |